renal cell carcinoma
Allarity Therapeutics Facing Potential Legal Action for Violation of SEC Laws
The SEC warned of enforcement action regarding Allarity's disclosures about FDA interactions seeking approval for dovitinib and its companion diagnostic.
Merck, Moderna Personalized Neoantigen Vaccine, Keytruda Combo Still Benefiting Melanoma Patients
Premium
After three years of follow-up, mRNA-4157 plus Keytruda led to a 49 percent reduction in the risk of disease recurrence or death versus Keytruda alone.
Dragonfly Therapeutics to Study DF9001 With Keytruda in EGFR-Expressing Solid Tumors
The Phase I trial will explore the combination in renal cell and head and neck cancers expressing EGFR.
Kura Oncology Begins Phase I Trial of KO-2806 in RAS-Altered Cancers
The firm began treating patients in the renal cell carcinoma cohort of the trial and expects to begin dosing another cohort in KRAS-mutant NSCLC.
Myriad Genetics, MD Anderson Partner to Study MRD Testing in Renal Cell Carcinoma
Researchers will explore whether Myriad's Precise MRD test can be used to inform treatment, monitor disease progression, and track treatment response.